Sanofi Market capitalization 2024

Sanofi Market capitalization

106.68 B EUR

Sanofi Dividend yield

4.18 %

Ticker

SAN.PA

ISIN

FR0000120578

WKN

920657

In 2024, Sanofi's market cap stood at 106.68 B EUR, a -13.86% increase from the 123.85 B EUR market cap in the previous year.

The Sanofi Market capitalization history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)NET INCOME (undefined EUR)
2029e58.0255,5114.55
2028e56.5956,9113.94
2027e56.0857,4313.43
2026e53.2760,4711.88
2025e50.8663,3211.05
2024e47.5167,799.74
202346.4469,355.4
202245.3969,838.37
202139.1868,726.22
202037.3767,4612.29
201937.6368,172.75
201835.6867,954.31
201736.2267,948.42
201634.769,164.71
201534.8668,684.29
20143268,034.39
201331.2967,083.72
201235.9669,144.89
201135.0668,905.69
201034.0472,395.47
200931.2374,045.27
200828.8274,543.85
200729.2174,085.26
200629.4974,274.01
200528.5173,462.26
200415.7371,791.99

Sanofi Aktienanalyse

What does Sanofi do?

Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Sanofi's Market Capitalization

Sanofi's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Sanofi's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Sanofi's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Sanofi’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Sanofi Stock

What is the current Sanofi market capitalization?

The current market capitalization of Sanofi is 106.68 B EUR.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Sanofi.

How has the market capitalization of Sanofi developed in recent years?

The market capitalization of Sanofi has increased/decreased by -13.86% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Sanofi?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Sanofi?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Sanofi have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Sanofi pay?

Over the past 12 months, Sanofi paid a dividend of 3.56 EUR . This corresponds to a dividend yield of about 4.18 %. For the coming 12 months, Sanofi is expected to pay a dividend of 3.76 EUR.

What is the dividend yield of Sanofi?

The current dividend yield of Sanofi is 4.18 %.

When does Sanofi pay dividends?

Sanofi pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Sanofi?

Sanofi paid dividends every year for the past 26 years.

What is the dividend of Sanofi?

For the upcoming 12 months, dividends amounting to 3.76 EUR are expected. This corresponds to a dividend yield of 4.41 %.

In which sector is Sanofi located?

Sanofi is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sanofi kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sanofi from 5/15/2024 amounting to 3.76 EUR, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.

When did Sanofi pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Sanofi in the year 2023?

In the year 2023, Sanofi distributed 3.313 EUR as dividends.

In which currency does Sanofi pay out the dividend?

The dividends of Sanofi are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sanofi stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Sanofi

Our stock analysis for Sanofi Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanofi Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.